ScreenerHero

NAMSW NewAmsterdam Pharma Company N.V. - Warrant

NAS · US · Healthcare · Biotechnology · newamsterdampharma.com
11.40USD-0.78%Mkt Cap: —P/E: —

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value—
Revenue (TTM)7.12M USD
Gross Profit7.12M USD
Net Income (TTM)-203.82M USD
Revenue/Share0.06 USD
Last Price11.40 USD
Fiscal Year End—
MR Quarter—
Employees100
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B2.05
EPS (TTM)—
EPS (Forward)—
52W Range
11.370% of range30.45
52W High30.45 USD
52W Low11.37 USD
Profitability
Gross Margin100.00%
Oper. Margin-1752.61%
EBITDA Margin0.00%
Profit Margin-905.74%
ROE-29.82%
ROA-26.49%
Growth
Revenue Growth-80.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-147.78M USD
CapEx (TTM)246.00K USD
FCF Margin-636.97%
FCF Yield—
Net Debt-633.77M USD
Net Debt/EBITDA2.60
Balance Sheet
Debt/Equity0.00
Current Ratio9.03
Quick Ratio8.76
Book Value/Sh5.37 USD
Cash/Share5.30 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float81.50M
Insiders—
Institutions—
Technical
SMA 5014.58 (-21.8%)
SMA 20020.20 (-43.6%)
Beta0.10
S&P 52W Chg15.78%
Avg Vol (30d)2.23K
Avg Vol (10d)170
Technical Indicators
RSI (14)19.3
MACD-1.7589
MACD Signal-1.5059
MACD Hist.-0.2530
BB Upper19.27 USD
BB Middle14.47 USD
BB Lower9.678 USD
BB Width66.26%
ATR (14)0.5391 USD
Vol Ratio (20d)0.40x